Cortexyme, Inc. Contracts & Agreements

54 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Separation Agreement, by and between Cortexyme, Inc. and Michael Detke, dated as of May 2, 2022
Separation Agreements
Cortexyme, Inc.
Biotechnology
DE
2022
2019 Equity Incentive Plan and forms of stock award agreements thereunder
Bonus & Incentive Agreements
Cortexyme, Inc.
2024
Accession, Amendment and Restatement Agreement to the Finance Contract relating to the Finance Contract dated 24 July 2020, as amended from time to time, by and between the...
Investment Agreements
Cortexyme, Inc.
2024
Autonomous First Demand Guarantee (Garanzia Autonoma a Prima Richiesta) by and between the Company, EryDel Italy, Inc., EryDel US, Inc., EryDel S.p.A, and the European Investment...
Guarantee Agreements
Cortexyme, Inc.
2024
Transition and Separation Agreement between Quince Therapeutics, Inc. and Karen Smith, dated as of August 4, 2023
Separation Agreements
Cortexyme, Inc.
2023
Offer Letter between Quince Therapeutics, Inc. and Charles Ryan, dated as of August 1, 2023
Cortexyme, Inc.
2023
Executive Change in Control and Severance Agreement between Quince Therapeutics, Inc. and Charles Ryan, dated as of September 1, 2023
Change of Control Agreements
Cortexyme, Inc.
2023
Amendment No. 3 to License Agreement dated June 22, 2023 by and between Purdue Research Foundation and Novosteo Inc
License Agreements
Cortexyme, Inc.
2023
Stock Purchase Agreement, dated as of July 21, 2023, by and among Quince Therapeutics, Inc., EryDel Italy, Inc., EryDel S.p.A., certain holders and the managers set forth on...
Stock Agreements
Cortexyme, Inc.
2023
Lighthouse Purchase Agreement
Purchase Agreements
Cortexyme, Inc.
2023
Rights Agreement dated as of April 5, 2023, between Quince Therapeutics, Inc. and American Stock Transfer & Trust Company, LLC, which includes the form of Certificate of...
Purchase Agreements
Cortexyme, Inc.
2023
Second Amendment to License Agreement, dated as of July 22, 2022, by and between Purdue Research Foundation and Novosteo, Inc
License Agreements
Cortexyme, Inc.
2022
Employment Offer Letter, by and between Cortexyme, Inc. and Brendan Hannah, dated May 9, 2022
Employment Agreements
Cortexyme, Inc.
2022
Employment Offer Letter, by and between Cortexyme, Inc. and Karen Smith, dated May 9, 2022
Employment Agreements
Cortexyme, Inc.
2022
Employment Offer Letter, by and between Cortexyme, Inc. and Dirk Thye, dated May 9, 2022
Employment Agreements
Cortexyme, Inc.
Biotechnology
CA
2022
Separation Agreement, by and between Cortexyme, Inc. and Caryn G. McDowell, dated as of May 19, 2022
Separation Agreements
Cortexyme, Inc.
Biotechnology
CA
2022
Executive Change in Control and Severance Agreement, by and between Cortexyme, Inc. and Brendan Hannah, dated as of May 19, 2022
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CA
2022
Executive Change in Control and Severance Agreement, by and between Cortexyme, Inc. and Karen Smith, dated as of May 19, 2022
Change of Control Agreements
Cortexyme, Inc.
2022
Executive Change in Control and Severance Agreement, by and between Cortexyme, Inc. and Dirk Thye, dated as of May 19, 2022
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CA
2022
Separation Agreement, by and between Cortexyme, Inc. and Christopher Lowe, dated as of June 10, 2022
Separation Agreements
Cortexyme, Inc.
Biotechnology
CA
2022
Sublease Agreement, by and between Cortexyme, Inc. and ICON Clinical Research, LLC, dated as of May 5, 2022
Lease Agreements
Cortexyme, Inc.
2022
Consent to Sublease, by and between Cortexyme, Inc. and ICON Clinical Research, LLC, dated as of June 8, 2022
Lease Agreements
Cortexyme, Inc.
2022
Separation Agreement, by and between Cortexyme, Inc. and Leslie Holsinger, dated as of July 31, 2022
Separation Agreements
Cortexyme, Inc.
2022
Amended and Restated Outside Director Compensation Policy
Compensation Agreements
Cortexyme, Inc.
Biotechnology
2022
License Agreement dated June 3, 2020, by and between Purdue Research Foundation and Novosteo Inc
License Agreements
Cortexyme, Inc.
Biotechnology
IN
2022
Amendment No. 1 to License Agreement dated March 21, 2022 by and between Purdue Research Foundation and Novosteo Inc
License Agreements
Cortexyme, Inc.
Biotechnology
2022
Agreement and Plan of Merger and Reorganization, dated as of May 9, 2022, by and among Cortexyme, Inc., Novosteo Inc., Quince Merger Sub I, Inc., Quince Merger Sub II, LLC and...
Merger Agreements
Cortexyme, Inc.
2022
Severance Agreement, dated February 1, 2022, between Casey Lynch and the Registrant
Severance Agreements
Cortexyme, Inc.
2022
Severance Agreement, dated February 1, 2022, between Stephen Dominy and the Registrant
Severance Agreements
Cortexyme, Inc.
Biotechnology
CA
2022
Open Market Sale AgreementSM dated December 23, 2021, by and between Cortexyme, Inc. and Jefferies LLC
Cortexyme, Inc.
2021
Change in Control and Severance Agreement, by and between Cortexyme Inc. and Ted Monohon, dated as of September 21, 2021
Change of Control Agreements
Cortexyme, Inc.
2021
Change in Control and Severance Agreement, by and between Cortexyme Inc. and Casey C. Lynch, dated as of May 19, 2021
Change of Control Agreements
Cortexyme, Inc.
2021
Change in Control and Severance Agreement, by and between Cortexyme Inc. and Caryn McDowell, dated as of May 18, 2021
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CA
2021
Change in Control and Severance Agreement, by and between Cortexyme Inc. and Christopher Lowe, dated as of May 18, 2021
Change of Control Agreements
Cortexyme, Inc.
2021
Change in Control and Severance Agreement, by and between Cortexyme Inc. and Leslie Holsinger, dated as of May 18, 2021
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CA
2021
Change in Control and Severance Agreement, by and between Cortexyme Inc. and Michael Detke, dated as of May 21, 2021
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CA
2021
Change in Control and Severance Agreement, by and between Cortexyme Inc. and Stephen S. Dominy, M.D., dated as of May 19, 2021
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CA
2021
Third Amendment to Sub-Sublease by and between Cortexyme, Inc. and Verily Life Sciences LLC dated July 15, 2021
Cortexyme, Inc.
2021
Description of Securities
Cortexyme, Inc.
Biotechnology
2021
Second Amendment to Sub-Sublease by and between Cortexyme, Inc. and Verily Life Sciences LLC dated May 26, 2020
Cortexyme, Inc.
2020
Separation Agreement by and between Kristen Gafric and Cortexyme, Inc., dated as of April 27, 2020
Separation Agreements
Cortexyme, Inc.
2020
Form of Executive Change in Control and Severance Agreement
Change of Control Agreements
Cortexyme, Inc.
2020
Description of Securities
Cortexyme, Inc.
2020
Form of Stock Purchase Agreement
Stock Agreements
Cortexyme, Inc.
2020
Amendment No. 1 to Sub-Sublease by and between Cortexyme, Inc. and Verily Life Sciences LLC dated April 2, 2019
Cortexyme, Inc.
2019
Form of Underwriting Agreement
Underwriting Agreements
Cortexyme, Inc.
2019
Specimen Stock Certificate
Stock Agreements
Cortexyme, Inc.
Biotechnology
2019
Form of Indemnification Agreement between Cortexyme, Inc. and each of its officers and directors
Indemnification Agreements
Cortexyme, Inc.
Biotechnology
DE
2019
2019 Equity Incentive Plan and forms of stock award agreements thereunder
Bonus & Incentive Agreements
Cortexyme, Inc.
2019
2019 Employee Stock Purchase Plan
Stock Agreements
Cortexyme, Inc.
2019
Amended and Restated Investors Rights Agreement by and among Cortexyme, Inc. and certain holders of its capital stock, dated May 23, 2018
Stock Agreements
Cortexyme, Inc.
Biotechnology
CA
2019
Sub-Sublease Agreement by and between Cortexyme, Inc. and Verily Life Sciences LLC, dated June 18, 2018
Cortexyme, Inc.
2019
2014 Stock Plan, as amended as of November 28, 2018, and related forms of stock award agreements
Stock Agreements
Cortexyme, Inc.
Biotechnology
CA
2019
Executive Incentive Bonus Plan
Bonus & Incentive Agreements
Cortexyme, Inc.
Biotechnology
CA
2019